{"id":99805,"date":"2023-06-09T00:00:00","date_gmt":"2023-06-09T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2023\/06\/09\/survival-noninferior-with-heart-donated-after-circulatory-death\/"},"modified":"2023-06-12T17:16:47","modified_gmt":"2023-06-12T17:16:47","slug":"survival-noninferior-with-heart-donated-after-circulatory-death","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2023\/06\/09\/survival-noninferior-with-heart-donated-after-circulatory-death\/","title":{"rendered":"Survival Noninferior With Heart Donated After Circulatory Death"},"content":{"rendered":"<h3>\n<p>Risk-adjusted six-month survival noninferior for patients receiving heart from circulatory-death, brain-death donor<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><\/p>\n<p><b><\/b><\/p>\n<p>FRIDAY, June 9, 2023 (HealthDay News) &#8212; Risk-adjusted survival at six months after transplantation is noninferior for patients receiving a heart after the circulatory death of a donor or after brain death of a donor, according to a study published in the June 8 issue of the <em>New England Journal of Medicine<\/em>.<\/p>\n<p>Jacob N. Schroder, M.D., from Duke University Medical Center in Durham, North Carolina, and colleagues conducted a randomized, noninferiority trial involving adult candidates for heart transplantation who were assigned to receive a heart after the circulatory death of the donor or a heart from a donor after brain death if that heart was available first or to receive only a heart that had been preserved with the use of traditional cold storage after the brain death of the donor (circulatory-death and brain-death groups, respectively). Risk-adjusted survival at six months was examined as the primary end point.<\/p>\n<p>The as-treated primary analysis included 80 patients who received a heart from a circulatory-death donor and 86 who received a heart from a brain-death donor. The researchers found that in the as-treated population, the risk-adjusted six-month survival was 94 and 90 percent among recipients of a heart from a circulatory-death donor and from a brain-death donor, respectively (least-squares mean difference, \u00e2\u0088\u00923 percentage points). No substantial differences were seen between the groups in the mean per-patient number of serious adverse events associated with the heart graft at 30 days posttransplant.<\/p>\n<p>&#8220;This should eliminate any barriers for transplant centers to offer this to their patients because we now have objective, randomized data showing both types of hearts are equivalent,&#8221; Schroder said in a statement.<\/p>\n<p>The study was funded by TransMedics.<\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2212438\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe2303928\" target=\"_blank\" rel=\"noopener\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2023 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Risk-adjusted six-month survival noninferior for patients receiving heart from circulatory-death, brain-death donor<\/p>\n","protected":false},"author":6,"featured_media":99886,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-99805","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/99805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=99805"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/99805\/revisions"}],"predecessor-version":[{"id":99885,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/99805\/revisions\/99885"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/99886"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=99805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=99805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=99805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}